Abstract
Clinical Outcomes and CNS Relapse Risk in Patients with Primary Cutaneous DLBCL, Leg Type Treated in the Rituximab Era: Long-Term Follow-up of a Single-Center Experience
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have